Multicentre, open label, randomised controlled trial comparing intermittent versus daily treatment for non-cavitary nodular/bronchiectatic Mycobacterium avium complex lung disease with rifampicin, ethambutol and clarithromycin (iREC): study protocol

Introduction Standard treatment for nodular/bronchiectatic Mycobacterium avium complex lung disease (NB MAC-LD), excluding severe-status cases, differs between Japan and other countries. Internationally, three-drug combination intermittent treatment (three times a week administration) with macrolide...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Akiko M Saito, Yoshikazu Inoue, Taku Nakagawa, Hiroya Hashimoto, Mitsuaki Yagi, Yoshihito Kogure, Masahiro Sekimizu, Kenji Ogawa
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	BMJ Publishing Group 2019-10-01
Ráidu:	BMJ Open Respiratory Research
Liŋkkat:	https://bmjopenrespres.bmj.com/content/6/1/e000434.full
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!